Ortho-Bromophenylpiperazine

Pharmaceutical compound From Wikipedia, the free encyclopedia

ortho-Bromophenylpiperazine (oBPP), also known as 2-bromophenylpiperazine (2-BPP), is a monoamine releasing agent of the phenylpiperazine family.[1] It acts as a serotonin–norepinephrine–dopamine releasing agent (SNDRA), with EC50Tooltip half-maximal effective concentration values of 132 nM for serotonin, 33 nM for norepinephrine, and 250 nM for dopamine in rat brain synaptosomes.[1] The drug was first described in the scientific literature by 2012.[1]

Other namesoBPP; 2-Bromophenylpiperazine; 2-BPP; 2-Bromo-PP
CAS Number
Quick facts Clinical data, Other names ...
ortho-Bromophenylpiperazine
Clinical data
Other namesoBPP; 2-Bromophenylpiperazine; 2-BPP; 2-Bromo-PP
Drug classSerotonin–norepinephrine–dopamine releasing agent
Identifiers
  • 1-(2-bromophenyl)piperazine
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
ECHA InfoCard100.199.072 Edit this at Wikidata
Chemical and physical data
FormulaC10H13BrN2
Molar mass241.132 g·mol−1
3D model (JSmol)
  • C1CN(CCN1)C2=CC=CC=C2Br
  • InChI=1S/C10H13BrN2/c11-9-3-1-2-4-10(9)13-7-5-12-6-8-13/h1-4,12H,5-8H2
  • Key:JVTRURBMYILQDA-UHFFFAOYSA-N
Close

See also

References

Related Articles

Wikiwand AI